Diagnosis and Treatment of Non-24-h Sleep–Wake Disorder in the Blind-Reference-Cited by-同舟云学术

Diagnosis and Treatment of Non-24-h Sleep–Wake Disorder in the Blind

Published:2017-02-22 Issue:6 Volume:77 Page:637-650
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Emens Jonathan S.,Eastman Charmane I.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s40265-017-0707-3.pdf

Reference84 articles.

1. American Academy of Sleep Medicine. The international classification of sleep disorders. Diagnostic and coding manual. 3rd ed. Darien: American Academy of Sleep Medicine; 2014.

2. Keating GM. Tasimelteon: a review in non-24-hour sleep–wake disorder in totally blind individuals. CNS Drugs. 2016;30:461–8.

3. Dhillon S, Clarke M. Tasimelteon: first global approval. Drugs. 2014;74(4):505–11.

4. Buhr ED, Takahashi JS. Molecular components of the mammalian circadian clock. Handb Exp Pharmacol. 2013;217:3–27.

5. LeGates TA, Fernandez DC, Hattar S. Light as a central modulator of circadian rhythms, sleep and affect. Nat Rev Neurosci. 2014;15(7):443–54.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronobiotic and cytoprotective activity of melatonin in the cardiovascular system. Doses matter;npj Biological Timing and Sleep;2024-09-09

2. The parent and family impact of CLN3 disease: an observational survey-based study;Orphanet Journal of Rare Diseases;2024-03-18

3. Significance of Melatonin in the Regulation of Circadian Rhythms and Disease Management;Molecular Neurobiology;2024-01-11

4. Genetics of Chronotype and Circadian Rhythm Disorders;Genetics of Sleep and Sleep Disorders;2024

5. Melatonin as a chronobiotic/cytoprotective agent in bone. Doses involved;Journal of Pineal Research;2023-12-11